WHO ICTRP trial
Evaluering af p53-pulset dendritiske celler i kombination med aromatase…
EUCTR2007-007596-16-DK · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2007-007596-16-DK |
|---|---|
| Public title | Evaluering af p53-pulset dendritiske celler i kombination med aromatase inhibitor som behandling til brystkræft-patienter med recidiv / progression efter adjuverende eller 1. linje endokrin behandling. |
| Scientific title | Evaluering af p53-pulset dendritiske celler i kombination med aromatase inhibitor som behandling til brystkræft-patienter med recidiv / progression efter adjuverende eller 1. linje endokrin behandling. |
| Primary sponsor | CCIT Center for Cancer ImmunTerapi, Herlev Hospital, Hæmatologisk afd 54P4 |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Denmark |
| Conditions | metastatisk eller lokal avanceret brystkræft MedDRA version: 9.1 Level: LLT Classification code 10065348 Term: Breast adenocarcinoma metastatic |
| Interventions | Product Name: p53 peptid pulset DC Pharmaceutical Form: Injection* INN or Proposed INN: p53 peptid pulset dendritiske celler Concentration type: not less then Concentration number: 5 x 10e6 celler/v- Trade Name: proleukin Pharmaceutical… |
| Registration date | Nov 6, 2008 |
| Target size | 100 |
| Secondary IDs | MAp53.02. |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: